Product Description

Cyebulin 0.5mg Injection contains eribulin mesylate, an anticancer medication used in the treatment and management of certain advanced cancers. It is primarily used for adults with metastatic breast cancer that has spread to other parts of the body and who have received prior chemotherapy treatments. The medicine works by interfering with the microtubule structures that help cancer cells divide and multiply, thereby blocking the cell cycle and ultimately killing cancer cells. Cyebulin may be used alone or in combination with other anticancer therapies as part of a comprehensive oncology treatment plan. It is administered as an intravenous infusion by trained healthcare professionals, with dosage and scheduling determined by the treating oncologist based on patient condition and treatment response. Regular monitoring throughout the course of therapy is recommended to ensure safety and effectiveness.